Zomedica Corp Ordinary Shares ZOMDF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
Zomedica Announces Strategic Collaboration with Boehringer Ingelheim Animal Health Canada Inc. to Expand Equine Endocrine Diagnostic Testing Using TRUFORMA(R) Platform
-
Zomedica Announces "Fourth Friday at Four" Webinar on August 28, 2026: Zomedica International: Building a Global Platform for Veterinary Innovation
-
Zomedica Announces Record Second Quarter Revenue of $9.5 Million, Up 37% Year-Over-Year, Net Loss Reduced 49%, with $44.1 Million in Liquidity
-
Zomedica Launches the PulseVet Acoustic Muffler(TM) Accessory for PulseVet(R) Shock Wave System
-
Zomedica Announces "Fourth Friday at Four" Webinar on July 24, 2026: Zomedica's Sales Organization - From Strategy to the Clinic
-
Zomedica's Assisi Loop(R) Products Designated "Fear Free(R)" as Alliance to Advance Low Stress Care and Pet Wellbeing Continues with Fear Free, LLC
-
Zomedica Announces "Fourth Friday at Four" Webinar on June 26, 2026: The Five Pillars of Zomedica - Framework for Clinical Value and Shareholder Returns
Trading Information
- Previous Close Price
- $0.09
- Day Range
- $0.08–0.09
- 52-Week Range
- $0.04–0.16
- Bid/Ask
- $0.08 / $0.09
- Shares Outstanding
- 979.95M
- Market Cap
- $82.95M
- Volume/Avg
- 533,994 / 864,811
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 2.26
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
Zomedica Corp is a veterinary health company creating products for companion animals (canine, feline and equine) by focusing on the unmet needs of clinical veterinarians. The company's product portfolio includes diagnostics and therapeutics that emphasize patient health and practice health. The company is focused on the final development and commercialization of its TRUFORMA platform, which detects thyroid disorders in dogs & cats and adrenal disorders in dogs. Its segments consist of Diagnostics, Therapeutic Devices, and Development Services. It earns the majority of revenue from the therapeutics segment, which consists of Assisi, PulseVet, and VETIGEL products.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Core
- Total Number of Employees
- 141
- Website
- https://www.zomedica.com
Valuation
|
Metric
|
ZOMDF
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 0.78 |
Price/Sales | 2.26 |
Price/Cash Flow | — |
Price/Earnings
ZOMDF
Financial Strength
|
Metric
|
ZOMDF
|
|---|---|
Quick Ratio | 5.57 |
Current Ratio | 6.43 |
Interest Coverage | — |
Quick Ratio
ZOMDF
Profitability
|
Metric
|
ZOMDF
|
|---|---|
Return on Assets (Normalized) | −13.08% |
Return on Equity (Normalized) | −14.33% |
Return on Invested Capital (Normalized) | −15.69% |
Return on Assets
ZOMDF
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| LOCK|!BP$!$? | LOCK|&R@<C | $195B | |||
| Stryker Corp
SYK
| LOCK|HF!C?>% | LOCK|>C$ | $127B | |||
| Medtronic PLC
MDT
| LOCK|ZYZt^r | LOCK|R!Qk | $118B | |||
| Boston Scientific Corp
BSX
| LOCK|$DW#@l | LOCK|vxGnj | $73B | |||
| Edwards Lifesciences Corp
EW
| LOCK|$>gr>zf | LOCK|wZ%&$ | $52B | |||
| DexCom Inc
DXCM
| LOCK|HD&!<?% | LOCK|W&fK | $34B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| LOCK|T@S$^$x | LOCK|#p | $33B | |||
| Koninklijke Philips NV ADR
PHG
| LOCK|XC | LOCK|$< | $27B | |||
| Steris PLC
STE
| LOCK|yyXDvMJ | LOCK|LlzLJ | $23B | |||
| Zimmer Biomet Holdings Inc
ZBH
| LOCK|hWM><$m | LOCK|^vK | $19B |
United States